Chimerism and Tolerance Without GVHD or Engraftment Syndrome in HLA-Mismatched Combined Kidney and Hematopoietic Stem Cell TransplantationJoseph R. Leventhal, Suzanne T. Ildstad, Michaël Abécassis et al.|Science Translational Medicine|2012Cited by 475
Risk Factors for Graft-versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation Using Post-Transplant CyclophosphamideAnnie Im, Richard F. Olsson, Armin Rashidi et al.|Transplantation and Cellular Therapy|2020Cited by 66
A GRAFT ENGINEERING METHOD TO ALLOW BONE MARROW TRANSPLANTATION (BMT) FOR MORE HIGHLY MISMATCHED RECIPIENTS WITH LEUKEMIA: MULTIVARIATE ANALYSIS OF A PHASE I/II PROTOCOL.Suzanne T. Ildstad, Roger H. Herzig, Pamela Crilley et al.|Transplantation|2000Cited by 2
LOSS AND RECOVERY OF IMMATURE AND MATURE PERIPHERAL BLOOD POPULATIONS FOLLOWING LOW LEVEL TBI AND COMBINED KIDNEY/BONE MARROW TRANSPLANTATION.Christina L. Kaufman, Frederick R. Bentley, Suzanne T. Ildstad et al.|Transplantation|2000Cited by 0
SUMMARY OF A PHASE II PROTOCOL TO ATTEMPT TO INDUCE MIXED CHIMERISM AND DONOR-SPECIFIC TOLERANCE TO RENAL AND CARDIAC ALLOGRAFTS.Suzanne T. Ildstad, Frederick R. Bentley, Roger H. Herzig et al.|Transplantation|2000Cited by 0